DAVID BATES to Costs and Cost Analysis
This is a "connection" page, showing publications DAVID BATES has written about Costs and Cost Analysis.
Connection Strength
0.201
-
Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc. 2008 Sep-Oct; 15(5):647-53.
Score: 0.073
-
The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 Jan 22-29; 277(4):307-11.
Score: 0.033
-
Impact of robotic antineoplastic preparation on safety, workflow, and costs. J Oncol Pract. 2012 Nov; 8(6):344-9, 1 p following 349.
Score: 0.024
-
The costs and savings associated with prevention of adverse events by critical care nurses. J Crit Care. 2009 Sep; 24(3):471.e1-7.
Score: 0.018
-
Costs of adverse events in intensive care units. Crit Care Med. 2007 Nov; 35(11):2479-83.
Score: 0.017
-
Benefits of information technology-enabled diabetes management. Diabetes Care. 2007 May; 30(5):1137-42.
Score: 0.017
-
Overcoming the barriers to the implementing computerized physician order entry systems in US hospitals: perspectives from senior management. AMIA Annu Symp Proc. 2003; 975.
Score: 0.012
-
Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med. 1993 Sep 01; 119(5):370-6.
Score: 0.007